OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Brain-Derived Neurotrophic Factor: A Novel Dynamically Regulated Therapeutic Modulator in Neurological Disorders
Vivek Sharma, Thakur Gurjeet Singh, Amarjot Kaur, et al.
Neurochemical Research (2022) Vol. 48, Iss. 2, pp. 317-339
Closed Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Recent Advances in the Knowledge of the Mechanisms of Leptin Physiology and Actions in Neurological and Metabolic Pathologies
María E. Casado, Roberto Collado-Pérez, Laura M. Frago, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1422-1422
Open Access | Times Cited: 50

Sirtuin dysregulation in Parkinson's disease: Implications of acetylation and deacetylation processes
Sonia Dhiman, Ashi Mannan, Ayushi Taneja, et al.
Life Sciences (2024) Vol. 342, pp. 122537-122537
Closed Access | Times Cited: 10

Emerging Targets in Amyotrophic lateral sclerosis (ALS): The Promise of ATP-Binding Cassette (ABC) transporter Modulation
Maneesh Mohan, Ashi Mannan, Aayush Nauriyal, et al.
Behavioural Brain Research (2024) Vol. 476, pp. 115242-115242
Closed Access | Times Cited: 10

Recent updates on structural insights of MAO-B inhibitors: a review on target-based approach
Gurkaran Singh Baweja, Shankar Gupta, Bhupinder Kumar, et al.
Molecular Diversity (2023) Vol. 28, Iss. 3, pp. 1823-1845
Open Access | Times Cited: 22

Targeting brain‐derived neurotrophic factor in the treatment of neurodegenerative diseases: A review
Dong Wang, Zhi‐Chen Lang, Shi‐Nan Wei, et al.
Neuroprotection/Neuroprotection (Chichester, England. Print) (2024) Vol. 2, Iss. 2, pp. 67-78
Open Access | Times Cited: 6

Targeting TrkB–PSD-95 coupling to mitigate neurological disorders
Xin Yang, Yu‐Wen Alvin Huang, John Marshall
Neural Regeneration Research (2024) Vol. 20, Iss. 3, pp. 715-724
Open Access | Times Cited: 6

Anti-neuroinflammatory microRNA-146a-5p as a potential biomarker for neuronavigation-guided rTMS therapy success in medication resistant depression disorder
Giedrė Valiulienė, Vladas Valiulis, Aistė Zentelytė, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115313-115313
Open Access | Times Cited: 12

Brain-derived neurotrophic factor serum levels as a candidate biomarker for withdrawal in crack heroin dependence
Enam Alhagh Charkhat Gorgich, Mohammad Gol Rigi, Hamed Fanaei, et al.
Substance Abuse Treatment Prevention and Policy (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 4

Understanding the neurobiological mechanisms of LPS‑induced memory impairment
Ahmad Golkar, Mohammad Dalfardi, Mahdiyeh Hedayati‐Moghadam, et al.
Acta Neurobiologiae Experimentalis (2025)
Open Access

Insights into in silico analysis to explore the multitarget antidepressant role of Camellia sinensis
Diksha Choudhary, Rajwinder Kaur, Nidhi Rani, et al.
Journal of Biomolecular Structure and Dynamics (2025), pp. 1-13
Closed Access

β-glucan, a specific immuno-stimulant, produces rapid antidepressant effects by stimulating ERK1/2-dependent synthesis of BDNF in the hippocampus
Bingran Chen, Cheng Zhao, Hao‐Jie Zhu, et al.
European Journal of Pharmacology (2023) Vol. 961, pp. 176161-176161
Closed Access | Times Cited: 10

Comment on “Neurotoxicity and Outcomes from Developmental Lead Exposure: Persistent or Permanent?”
Lorenz S. Neuwirth, Bright U. Emenike
Environmental Health Perspectives (2024) Vol. 132, Iss. 4
Open Access | Times Cited: 3

Unlocking new avenues for neuropsychiatric disease therapy: the emerging potential of Peroxisome proliferator-activated receptors as promising therapeutic targets
Asmita Deka Dey, Ashi Mannan, Sonia Dhiman, et al.
Psychopharmacology (2024) Vol. 241, Iss. 8, pp. 1491-1516
Closed Access | Times Cited: 3

Pharmacological modulation of HIF-1 in the treatment of neuropsychiatric disorders
Diksha Sharma, Heena Khan, Amit Kumar, et al.
Journal of Neural Transmission (2023) Vol. 130, Iss. 12, pp. 1523-1535
Closed Access | Times Cited: 7

Functional modification of recombinant brain-derived neurotrophic factor and its protective effect against neurotoxicity
Chang Liu, Qi Yan, Xuying Ding, et al.
International Journal of Biological Macromolecules (2024) Vol. 267, pp. 131610-131610
Closed Access | Times Cited: 2

Association Between the Enriched Environment Level and Serum Brain-Derived Neurotrophic Factor (BDNF) in Patients with Major Depressive Disorder
Andrés Vega-Rosas, Mónica Flores‐Ramos, Gerardo Bernabé Ramírez-Rodríguez
Brain Sciences (2024) Vol. 14, Iss. 11, pp. 1137-1137
Open Access | Times Cited: 2

Impact of dietary plant flavonoids on 7,8‐dihydroxyflavone transepithelial transport in human intestinal Caco‐2 cells
Yufeng Chen, Guobin Xia, Chunfeng Wang, et al.
Food Science & Nutrition (2023) Vol. 11, Iss. 11, pp. 6888-6898
Open Access | Times Cited: 6

Reduced Levels of Lacrimal Glial Cell Line-Derived Neurotrophic Factor (GDNF) in Patients with Focal Epilepsy and Focal Epilepsy with Comorbid Depression: A Biomarker Candidate
А. А. Шпак, Flora Rider, Т. А. Дружкова, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16818-16818
Open Access | Times Cited: 5

Invited Perspective: Challenging the Dogma of Lead Neurotoxicity
Tomás R. Guilarte
Environmental Health Perspectives (2023) Vol. 131, Iss. 8
Open Access | Times Cited: 4

Dihydroergotamine and Bromocriptine: Potential Drugs for the Treatment of Major Depressive Disorder and Alzheimer’s Disease Comorbidity
Mengjie Fu, Qiuchen Wang, Lihui Gao, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 1

A comprehensive review on neurotrophic receptors and their implications in brain health: Exploring the neuroprotective potential of berries
Lakhwinder Singh, Ab Waheed Wani, Ramesh Kumar Sadawarti, et al.
Journal of Berry Research (2024)
Closed Access | Times Cited: 1

Mini review of molecules involved in altered postnatal neurogenesis in autism
Stanislavá Bukatova, Zuzana Bačová, Jana Osacká, et al.
International Journal of Neuroscience (2023) Vol. 134, Iss. 12, pp. 1429-1443
Closed Access | Times Cited: 2

Serum brain-derived neurotrophic factor levels as a predictor for Alzheimer disease progression
Meng‐Ju Tsai, Yung‐Shuan Lin, Chun‐Yu Chen, et al.
Journal of the Chinese Medical Association (2023) Vol. 86, Iss. 11, pp. 960-965
Open Access | Times Cited: 2

Up-regulation of systemic and local BDNF in non-allergic Nasal Polyps in China
Xiangmin Zhou, Qian Zhang, Yuzhu Wan Yuzhu Wan, et al.
Pakistan Journal of Medical Sciences (2024) Vol. 40, Iss. 5
Open Access

Cerebrolysin Concentrate: Therapeutic Potential for Severe Oral Apraxia After Stroke: A Case Report
Hyeonwoo Jeon, Doo-Young Kim
Brain & Neurorehabilitation (2024) Vol. 17, Iss. 2
Open Access

Page 1 - Next Page

Scroll to top